ID

24850

Description

Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876

Lien

https://clinicaltrials.gov/ct2/show/NCT00291876

Mots-clés

Versions (1)
  1. 19/08/2017 19/08/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

19 août 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK Hepatitis A Vaccine GSK Hepatitis A Vaccine MONTH 174 VISIT 21 SAE continued NCT00291876

Anglais

GSK Hepatitis A Vaccine GSK Hepatitis A Vaccine MONTH 174 VISIT 21 SERIOUS ADVERSE EVENT NCT00291876 SAE continued NCT00291876

1 Formulaires  
Study administration
Description

Study administration

Subject Number
Description

Subject Identifier

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Study vaccine Information
Description

Study vaccine Information

Vaccine
Description

(specify mixed or separate)

Type de données

text

Alias
UMLS CUI [1]
C0042210
Dose No
Description

Dose Number

Type de données

integer

Alias
UMLS CUI [1,1]
C1115464
UMLS CUI [1,2]
C0042210
UMLS CUI [1,3]
C1519255
Lot No
Description

Lot Number

Type de données

integer

Alias
UMLS CUI [1,1]
C2826710
UMLS CUI [1,2]
C0042210
Route / Site
Description

Administration Route

Type de données

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0042210
Date
Description

administration date

Type de données

date

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0042210
Concomitant medication / vaccination that could have contributed to this SAE
Description

Concomitant medication / vaccination that could have contributed to this SAE

Drug / vaccine
Description

concomitant medication

Type de données

text

Alias
UMLS CUI [1]
C2347852
Dosage
Description

Dosage

Type de données

text

Alias
UMLS CUI [1]
C0178602
Frequency
Description

Frequency

Type de données

text

Alias
UMLS CUI [1]
C3476109
Route
Description

Route

Type de données

text

Alias
UMLS CUI [1]
C0013153
Start Date
Description

concomitant medication start date

Type de données

date

Alias
UMLS CUI [1]
C2826734
End Date
Description

concomitant medication end date

Type de données

date

Alias
UMLS CUI [1]
C2826744
Relevant intercurrent illness & medical history that could have contributed to this SAE
Description

Relevant intercurrent illness & medical history that could have contributed to this SAE

Condition
Description

Condition

Type de données

text

Alias
UMLS CUI [1]
C0012634
Still present?
Description

Condition still present

Type de données

boolean

Alias
UMLS CUI [1,1]
C2745955
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C1519255
Drug(s) used to treat this SAE
Description

Drug(s) used to treat this SAE

Drug
Description

Drug

Type de données

text

Alias
UMLS CUI [1]
C0013227
Dosage
Description

Dosage

Type de données

text

Alias
UMLS CUI [1]
C0178602
Frequency
Description

Frequency

Type de données

text

Alias
UMLS CUI [1]
C3476109
Route
Description

Route

Type de données

text

Alias
UMLS CUI [1]
C0013153
Start date
Description

drug start date

Type de données

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
End Date
Description

drug end date

Type de données

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Surgical treatment for this SAE
Description

Surgical treatment for this SAE

Surgical treatment for this SAE, please specify
Description

Surgical treatment

Type de données

text

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C1519255
Description
Description

Description

Description (provide a brief narrative description of the SAE including relevant diagnostic findings, lab data & evolution of the events etc…)
Description

Description

Type de données

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1519255
AEGIS number
Description

AEGIS number

Type de données

text

Alias
UMLS CUI [1,1]
C0237753
UMLS CUI [1,2]
C0600091
Comments
Description

Comments

Comments
Description

Comments

Type de données

text

Alias
UMLS CUI [1]
C0947611
Retour au début de la page

Similar models

GSK Hepatitis A Vaccine GSK Hepatitis A Vaccine MONTH 174 VISIT 21 SERIOUS ADVERSE EVENT NCT00291876 SAE continued NCT00291876

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
Study vaccine Information
Vaccine
Item
Vaccine
text
C0042210 (UMLS CUI [1])
Dose Number
Item
Dose No
integer
C1115464 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Lot Number
Item
Lot No
integer
C2826710 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Administration Route
Item
Route / Site
text
C0013153 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
administration date
Item
Date
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Item Group
Concomitant medication / vaccination that could have contributed to this SAE
concomitant medication
Item
Drug / vaccine
text
C2347852 (UMLS CUI [1])
Dosage
Item
Dosage
text
C0178602 (UMLS CUI [1])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
concomitant medication start date
Item
Start Date
date
C2826734 (UMLS CUI [1])
concomitant medication end date
Item
End Date
date
C2826744 (UMLS CUI [1])
Item Group
Relevant intercurrent illness & medical history that could have contributed to this SAE
Condition
Item
Condition
text
C0012634 (UMLS CUI [1])
Condition still present
Item
Still present?
boolean
C2745955 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Item Group
Drug(s) used to treat this SAE
Drug
Item
Drug
text
C0013227 (UMLS CUI [1])
Dosage
Item
Dosage
text
C0178602 (UMLS CUI [1])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
drug start date
Item
Start date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
drug end date
Item
End Date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
Surgical treatment for this SAE
Surgical treatment
Item
Surgical treatment for this SAE, please specify
text
C0543467 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Description
Description
Item
Description (provide a brief narrative description of the SAE including relevant diagnostic findings, lab data & evolution of the events etc…)
text
C0678257 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
AEGIS number
Item
AEGIS number
text
C0237753 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
Comments
Comments
Item
Comments
text
C0947611 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial